Report Categories
View AllRecent Articles
View All
SATLW Satellogic expands global satellite imaging footprint as key driver of longterm sustainable revenue growth
AAPL Apple Q1 earnings beat by slim 11 margin stock flat as investors remain cautious on growth outlook
Invesco CurrencyShares Japanese Yen Trust FXY Volatility Lingers As Japanese Officials Decline To Confirm Suspected 345B FX Intervention During Golden Week
HHS Harte Hanks posts Q2 2025 5 cent per share loss stock falls 105 percent in todays regular trading
China Emerges as Major Rival in Humanoid Robot Race Tesla CEO Suggests
Flipkart Achieves RecordBreaking SingleDay Sales of 200 Million on Ecommerce Giants Largest Shopping Event
UDR Identified as One of Top Residential REITs for 2026 Key Factors Driving Interest
Gold Prices Hold Steady as Market Awaits Progress in USIran Peace Talks
Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal
Retail Hiring Surges in April Yet Consumer Caution Flags Potential Economic Shift
BMY Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Response
DSX Q4 2025 Earnings EPS Misses Estimates as Shipping Headwinds Persist
FHN Q1 2026 Earnings EPS Beats Estimates by 623 as Stock Edges Higher
SBSW Q2 2022 Earnings EPS Misses Estimates Stock Reacts Negatively
DLB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
AGNCP Q1 2026 Earnings Preferred Dividend Beats Estimates Shares Edge Higher
BRC Group Holdings Senior Notes RILYT Edge Lower as Bond Yields Test Resistance
Skyline Builders Group Holding SKBL Slips 482 Key Support in Focus
JFB Construction Holdings JFB Gains 318 as Shares Test Resistance Near 580
US Physical Therapy USPH Slips Slightly as Stock Consolidates Near Key Support
Columbia Financial CLBK Consolidates Near Support Amid Flat Trading Session
ATXG Q1 2025 Earnings Loss per Share of 025 and Stock Decline Highlight Ongoing Challenges
Trinity Biotech TRIB Q4 2024 Earnings Deep EPS Miss Weighs on Investor Sentiment
LCTX Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Reports No Revenue
ALT Q1 2026 Earnings Narrowed Loss and EPS Beat Signal Progress in Metabolic Pipeline
INCR Q2 2023 Earnings EPS Surprises 2868 Above Estimates Despite Negative Stock Reaction
IMMR Q3 2025 Earnings EPS Surges Past Estimates Stock Reacts Positively